1. Home
  2. RJF vs ONC Comparison

RJF vs ONC Comparison

Compare RJF & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Raymond James Financial Inc.

RJF

Raymond James Financial Inc.

HOLD

Current Price

$162.68

Market Cap

31.4B

Sector

Finance

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$331.25

Market Cap

34.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RJF
ONC
Founded
1962
2010
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.4B
34.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RJF
ONC
Price
$162.68
$331.25
Analyst Decision
Buy
Strong Buy
Analyst Count
12
12
Target Price
$181.00
$369.50
AVG Volume (30 Days)
1.1M
319.7K
Earning Date
10-22-2025
11-06-2025
Dividend Yield
1.23%
N/A
EPS Growth
6.19
N/A
EPS
10.30
0.58
Revenue
$14,015,000,000.00
$4,972,687,000.00
Revenue This Year
$13.65
$36.37
Revenue Next Year
$6.45
$22.04
P/E Ratio
$15.79
$566.55
Revenue Growth
9.52
53.47
52 Week Low
$117.57
$170.99
52 Week High
$177.66
$385.22

Technical Indicators

Market Signals
Indicator
RJF
ONC
Relative Strength Index (RSI) 58.23 46.47
Support Level $155.16 $325.00
Resistance Level $157.68 $345.58
Average True Range (ATR) 3.32 12.49
MACD 0.78 -2.95
Stochastic Oscillator 94.78 14.07

Price Performance

Historical Comparison
RJF
ONC

About RJF Raymond James Financial Inc.

Raymond James Financial is a diversified financial services firm that provides wealth management, investment banking, asset management, and capital markets services to individuals, corporations, and municipalities. The firm maintains an extensive catalogue of products and services across its business lines. However, the wealth management franchise generates the bulk of its revenues and earnings through a vast network of nearly 8,800 independent and employee-affiliated advisors, who collectively manage over $1.7 trillion in client assets as of fiscal year-end 2025. While Raymond James maintains a global footprint, the company derives over 90% of its revenue, and an even larger percentage of its operating income, from the United States.

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Share on Social Networks: